Kevin Norrett
Directeur des opérations chez CODEXIS, INC.
Fortune : 398 390 $ au 31/05/2024
Provenance du réseau au premier degré de Kevin Norrett
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Extinct | Biotechnology | 28 | |
| Public Company | Chemicals: Specialty | 22 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kevin Norrett via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| UCLA Anderson School of Management | College/University | Corporate Officer/Principal Masters Business Admin | |
Acepodia Biotechnologies, Ltd.
 Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Biotechnology | Director/Board Member Founder | |
| University of Denver | College/University | Masters Business Admin Masters Business Admin | |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | General Counsel Chief Executive Officer | |
| University of Alberta | College/University | Graduate Degree Doctorate Degree | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
National Resilience, Inc.
 National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Biotechnology | Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
| VERA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
| University of Virginia | College/University | Doctorate Degree Graduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| LaTrobe University | College/University | Masters Business Admin Masters Business Admin | |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Medical Specialties | General Counsel Director/Board Member | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Queen's University | College/University | Masters Business Admin Graduate Degree | |
Antheia, Inc.
 Antheia, Inc. Pharmaceuticals: OtherHealth Technology Antheia, Inc. provides supply of plant-based medicines and to transform the discovery, manufacture, and distribution of medicines. The company was founded by Kristy Hawkins, Christina Smolke, Kate Thodey, and Isis Trenchard. The company is headquartered in Menlo Park, CA. | Pharmaceuticals: Other | Chairman Director/Board Member | |
| University of California | College/University | Corporate Officer/Principal Graduate Degree | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
AAIPharma, Inc.
 AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Lexent Bio, Inc.
 Lexent Bio, Inc. Financial ConglomeratesFinance Lexent Bio, Inc. engages in the development of novel liquid biopsy technologies to manage cancer. The company was founded by Kenneth G. Nesmith, Haluk Tezcan, and John Spinosa and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member | |
The Climate Corp.
 The Climate Corp. Packaged SoftwareTechnology Services The Climate Corp. develops solutions for farming operations. Its products include FieldView Pro, FieldView Plus and FieldView Prime. The firm's proprietary climate FieldView platform combines hyper-local weather monitoring, agronomic modeling, and high-resolution weather simulations to deliver climate FieldView products, mobile SaaS solutions that help farmers improve profitability by making better informed operating and financing decisions. The company was founded by Siraj Khaliq and David Friedberg in 2006 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Entact Bio, Inc.
 Entact Bio, Inc. BiotechnologyHealth Technology Entact Bio, Inc. is a company that focuses on creating new medicines by enhancing protein function. The company is based in Watertown, MA. The company is a team of scientists, entrepreneurs, drug creators, and problem solvers who work together to bring new medicines to patients who currently have few options. The CEO of the company is Victoria M. Richon. The founder of the company grew up in chaos and instability in an undisclosed capital city and has always been passionate and motivated to help enhance and provide medical solutions. | Biotechnology | Director/Board Member | |
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Biotechnology | Director/Board Member | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| XENCOR, INC. | Biotechnology | Director/Board Member | |
| University of Kansas Medical School | College/University | Doctorate Degree | |
Argonne National Laboratory
 Argonne National Laboratory Miscellaneous Commercial ServicesCommercial Services Argonne National Laboratory provides research and technology services. Its research areas include computer science, energy, environmental management, and industrial technology. The company was founded in 1946 and is headquartered in Lemont, IL. | Miscellaneous Commercial Services | Director/Board Member | |
| Indiana University | College/University | Undergraduate Degree | |
| EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 39 |
| Canada | 9 |
| Taïwan | 2 |
| Australie | 2 |
| France | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 14 |
| Commercial Services | 8 |
| Finance | 2 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 173 |
| Corporate Officer/Principal | 89 |
| Independent Dir/Board Member | 65 |
| Undergraduate Degree | 34 |
| Director of Finance/CFO | 28 |
Relations les plus connectées
| Insiders | |
|---|---|
| Patrick Yang | 28 |
| Dennis Wolf | 23 |
| H. Parker | 22 |
| Rahul Singhvi | 22 |
| Gaurav Aggarwal | 21 |
| Andrew Allen | 18 |
| Georgia Erbez | 18 |
| Craig Collard | 18 |
| David Smith | 17 |
| Stephen Dilly | 15 |
| Andrew Sinclair | 14 |
| John Nicols | 14 |
| Jennifer Aaker | 13 |
| Laurie Heilmann | 13 |
| Barbara Klencke | 12 |
- Bourse
- Insiders
- Kevin Norrett
- Connexions Sociétés
